{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:20:42Z","timestamp":1775168442436,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1136\/ard.58.5.281","type":"journal-article","created":{"date-parts":[[2008,12,6]],"date-time":"2008-12-06T00:32:33Z","timestamp":1228523553000},"page":"281-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate"],"prefix":"10.1016","volume":"58","author":[{"given":"Oliver","family":"Sander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertraud","family":"Herborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Rau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.58.5.281_bib1","first-page":"302","article-title":"Goldsodiumthiomalat compared to low-dose methotrexate in the treatment of rheumatoid arthritis - a randomised double-blind 26-week trial","volume":"16","author":"Morrasut","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/36.3.345","article-title":"Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients","volume":"36","author":"Rau","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/rheumatology\/37.10.1060","article-title":"A 36-month comparative trial of methotrexate and goldsodiumthiomalate in the treatment of early active and erosive rheumatoid arthritis","volume":"37","author":"Menninger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/rheumatology\/37.11.1220","article-title":"Radiographic progression in early erosive rheumatoid arthritis: 12 month results from a randomised controlled trial comparing methotrexate and gold sodium thiomalate","volume":"37","author":"Rau","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib5","first-page":"753","article-title":"A randomised controlled trial of parenteral methotrexate compared with sodium aurothiomalate","volume":"15","author":"Suarez-Almazor","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/art.1780350203","article-title":"Longterm prospective study of the use of methotrexate in the treatment of rheumatoid arthritis","volume":"35","author":"Kremer","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/art.1780350202","article-title":"Longterm prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update","volume":"35","author":"Weinblatt","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib8","first-page":"34","article-title":"Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study","volume":"18","author":"Weinblatt","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib9","first-page":"1323","article-title":"Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases","volume":"18","author":"Sany","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/rheumatology\/28.2.147","article-title":"Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression","volume":"28","author":"Hanrahan","year":"1989","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib11","first-page":"1881","article-title":"Longterm treatment of destructive rheumatoid arthritis with methotrexate","volume":"24","author":"Rau","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib12","first-page":"994","article-title":"Termination of slow acting antirheumatic therapy in RA: A 14 year prospective evaluation of 1017 consecutive starts","volume":"17","author":"Wolfe","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib13","first-page":"40","article-title":"Methotrexate is continued over five years significantly longer than other second-line drugs in 536 private practice rheumatoid arthritis patients","volume":"33","author":"Pincus","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib14","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.1780331001","article-title":"The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis","volume":"33","author":"Felson","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib15","first-page":"S51","article-title":"Gold salts and methotrexate in daily practice. Short-term safety and efficacy in rheumatoid arthritis. [Abstract]","volume":"40","author":"Hern\u00e1ndez-Garc\u00eda","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib16","first-page":"S106","article-title":"The long-term efficacy and safety of disease modifying antirheumatic drugs (DMARD). Results of a meta-analysis of 1681 patients with rheumatoid arthritis (RA). [Abstract]","volume":"39","author":"Keyszer","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib17","first-page":"1814","article-title":"Mucocutaneous reactions to gold: a prospective study of 74 patients with rheumatoid arthritis","volume":"21","author":"van Gestel","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/art.1780220201","article-title":"Long term chrysiotherapy in rheumatoid arthritis","volume":"22","author":"Srinivasan","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0049-0172(85)90043-5","article-title":"Forty seven years experience with gold therapy in 1019 rheumatoid arthritis patients","volume":"13","author":"Lockie","year":"1985","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib20","first-page":"836","article-title":"Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness","volume":"22","author":"Suarez-Almazor","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/ard.54.11.881","article-title":"Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients","volume":"54","author":"De La Mata","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.58.5.281_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/ard.51.3.326","article-title":"Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate","volume":"51","author":"Svensson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.58.5.281_bib23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.48.9.730","article-title":"Association between gold induced skin rash and remission in patients with rheumatoid arthritis","volume":"48","author":"Caspi","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.58.5.281_bib24","first-page":"175","article-title":"Revision of diagnostic criteria for rheumatoid arthritis","volume":"9","author":"Ropes","year":"1958","journal-title":"Bull Rheum Dis"},{"key":"10.1136\/ard.58.5.281_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/028418517701800415","article-title":"Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films","volume":"18","author":"Larsen","year":"1977","journal-title":"Acta Radiol Diagn"},{"key":"10.1136\/ard.58.5.281_bib26","series-title":"WHO handbook for reporting results of cancer treatment","author":"Larsen","year":"1979"},{"key":"10.1136\/ard.58.5.281_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","article-title":"Development and validation of the European League Against Rheumatism Response Criteria for rheumatoid arthritis","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib28","first-page":"2094","article-title":"A new method of scoring radiographic change in rheumatoid arthritis","volume":"25","author":"Rau","year":"1998","journal-title":"J Rheumatol"},{"issue":"suppl 1","key":"10.1136\/ard.58.5.281_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03342627","article-title":"The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: An x-ray analysis","volume":"3","author":"Larsen","year":"1984","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01972255","article-title":"Multicentre controlled trial of the effects of different dosage of gold therapy, followed by maintenance dosage","volume":"6","author":"Cats","year":"1976","journal-title":"Agents Actions"},{"key":"10.1136\/ard.58.5.281_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/03009747709095448","article-title":"Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment","volume":"6","author":"Luukkainen","year":"1977","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-80-1-21","article-title":"Gold salts in the treatment of rheumatoid arthritis. A double blind study","volume":"80","author":"Sigler","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.58.5.281_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/art.1780160309","article-title":"A controlled trial of gold salt therapy in rheumatoid arthritis","volume":"16","year":"1973","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.48.1.25","article-title":"Erosion number and area progression in the wrists and hands of rheumatoid arthritis patients: a quantitative microfocal radiographic study","volume":"48","author":"Buckland-Wright","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.58.5.281_bib35","first-page":"243","article-title":"Quantitative microfocal radiography detects changes in erosion area in patients with early erosive rheumatoid arthritis treated with myocrisine","volume":"20","author":"Buckland-Wright","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/art.1780250508","article-title":"Clinical responses during gold therapy for rheumatoid arthritis","volume":"25","author":"Sharp","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib37","first-page":"S52","article-title":"The degree of functional improvement over 5 years of IM gold depends on initial disease duration. [Abstract]","volume":"40","author":"Munro","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib38","first-page":"S51","article-title":"High clinical remission rates following early therapy of active rheumatoid arthritis (RA) with aurothioglucose and low-dose triamcinolone. [Abstract]","volume":"40","author":"Roger","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02114394","article-title":"Can treatment with methotrexate influence the radiologic progression of rheumatoid arthritis?","volume":"9","author":"Drosos","year":"1990","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/03009748909099932","article-title":"Methotrexate treatment of rheumatoid arthritis: effects on radiological progression","volume":"18","author":"Reykdal","year":"1989","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib41","first-page":"S313","article-title":"A meta-analysis of treatment termination rates on parenteral gold and methotrexate in rheumatoid arthritis. [Abstract]","volume":"40","author":"Maetzel","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.58.5.281_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/ard.19.2.95","article-title":"Gold therapy in rheumatoid arthritis. Report of a multi-centre controlled trial","volume":"19","year":"1960","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.58.5.281_bib43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.20.4.335","article-title":"Report of the Research Sub-Committee of the Empire Rheumatism Council: Relations of toxic reactions in gold therapy to improvement in rheumatoid arthritis","volume":"20","year":"1961","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.58.5.281_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(83)90477-1","article-title":"Methotrexate therapy in rheumatoid arthritis: 15 years experience","volume":"75","author":"Hoffmeister","year":"1983","journal-title":"Am J Med"},{"issue":"suppl 3","key":"10.1136\/ard.58.5.281_bib45","first-page":"226","article-title":"Flare after discontinuation of \u201cineffective\u201d disease modifying anti rheumatic drug threatment in active rheumatoid arthritis. [Abstract]","volume":"24","author":"Sander","year":"1995","journal-title":"Rheumatology in Europe"},{"key":"10.1136\/ard.58.5.281_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(96)90535-8","article-title":"Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis","volume":"347","author":"ten Wolde","year":"1996","journal-title":"Lancet"},{"key":"10.1136\/ard.58.5.281_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7326\/0003-4819-33-1-163","article-title":"Gold therapy in early rheumatoid arthritis","volume":"33","author":"Adams","year":"1950","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.58.5.281_bib48","first-page":"1655","article-title":"The second course of gold","volume":"22","author":"Klinkhoff","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib49","first-page":"1657","article-title":"How low can you go? Use of very low dosage of gold in patients with mucocutaneous reactions","volume":"22","author":"Klinkhoff","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.58.5.281_bib50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/ard.56.4.235","article-title":"Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation","volume":"56","author":"ten Wolde","year":"1997","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672443642X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672443642X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.58.5.281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:42:25Z","timestamp":1737549745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672443642X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S000349672443642X"],"URL":"https:\/\/doi.org\/10.1136\/ard.58.5.281","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1999,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.58.5.281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}